Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Transkaryotic Therapies receives patent for Gene Activation technology

April 8, 1998

Targeted Genetics announces collaboration with NHLBI

April 7, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Inhale reports successful phase I and II results with drugs from Baxter collaboration

April 6, 1998

U.S. patent issues for GenVec's advanced gene therapy vectors

April 3, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Novel liposomal delivery system available for licensing from NCI/NIH

April 2, 1998

NIH offers gene expression detection technology for licensing

March 30, 1998

Demeter granted U.S. patent for peptide stabilization

March 30, 1998

PIN*POINT method available for licensing from NIH

March 27, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...